Skip to main content

Table 1 Clinicopathologic characteristics of patients with lung cancer

From: RETRACTED ARTICLE: MicroRNA-130b promotes lung cancer progression via PPARγ/VEGF-A/BCL-2-mediated suppression of apoptosis

Characteristics

All patients (N = 91) (%)

Gender

 

Male

38(42 %)

 

Female

53(58 %)

Smoking Status

 

Nonsmoker

19(21 %)

 

Smoker

72(79 %)

Tumor Location

 

Central

37(41 %)

 

Peripheral

54(59 %)

Tumor Subtypes

 

Adenocarcinoma

51(56 %)

 

Squamous Cell Carcinoma

40(44 %)

Differentiation

 

High

47(52 %)

 

Moderate-Poor

44(48 %)

LN Metastasis

 

Yes

55(60 %)

 

No

36(40 %)

Tumor Size

 

>3 cm

57(63 %)

 

<3 cm

34(37 %)

TNM Stage

 

I-II

39(43 %)

 

III-IV

52(57 %)

Mean Survival Time (months)

57.96